MAPT and Alzheimer disease: Subsequent research has confirmed that AdipoRon can pass through BBB and can protect against the development of AD pathologies, including promoting Aβ clearance [33], inhibiting tau hyperphosphorylation [34], and lowering neurofibrillary tangles (NFTs) [35].